Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays.

Patrick M Vanderboom1, Santosh Renuse1,2, Anthony D Maus1

  • 1Department of Laboratory Medicine and Pathology, Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, Minnesota 55905, United States.

Summary

Machine learning enhances targeted mass spectrometry assays for detecting SARS-CoV-2. This approach improves sensitivity in qualitative PRM assays compared to traditional methods, aiding in more accurate sample discrimination.

Related Concept Videos